NOVN / Novan Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Novan Inc
US ˙ NASDAQ ˙ US66988N1063
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier4.137.296 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Novan Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NOVN / Novan Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-04-07 BIERMAN JAMES L 1.000 3,4488 1.000 3,4488 3.449 0 3.3900 -58 -1,68
2022-03-28 BIERMAN JAMES L 1.000 3,4500 1.000 3,4500 3.450
2022-03-25 BIERMAN JAMES L 2.000 3,5450 2.000 3,5450 7.090
2022-03-18 PALMOUR JOHN W 10.000 3,6350 10.000 3,6350 36.350
2022-03-18 GAY JOHN M. 1.000 3,5000 1.000 3,5000 3.500
2022-03-17 PALMOUR JOHN W 5.000 3,3410 5.000 3,3410 16.705
2022-03-16 PALMOUR JOHN W 5.000 3,3370 5.000 3,3370 16.685
2021-03-26 STAFFORD PAULA B 70.000 1,4300 7.000 14,3000 100.100
2020-03-03 PALMOUR JOHN W 200.000 20.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NOVN / Novan Inc Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NOVN / Novan Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-06-27 SANDERS MACHELLE 11.553 0,4082 11.553 0,4082 4.716 28 0.0941 -3.628 -76,94
2019-07-02 Malin Life Sciences Holdings Ltd 6.287 2,7500 629 27,5000 17.289
2019-07-01 Malin Life Sciences Holdings Ltd 913 2,7400 91 27,4000 2.502
2019-06-28 Malin Life Sciences Holdings Ltd 17.800 2,6900 1.780 26,9000 47.882

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NOVN / Novan Inc Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-06-27 2023-06-27 4 SANDERS MACHELLE NOVN Common Stock S - Sale D 0,4082 -11.553 -5 25.248
2023-06-08 2023-06-07 4 Geer W Kent NOVN Common Stock M - Exercise D 36.101 37.683
2023-06-08 2023-06-07 4 GAY JOHN M. NOVN Common Stock F - Taxes D -20.669 46.831
2023-06-08 2023-06-07 4 GAY JOHN M. NOVN Common Stock M - Exercise D 65.000 67.500
2023-06-08 2023-06-07 4 KEEGAN ROBERT J NOVN Common Stock M - Exercise D 36.101 42.404
2023-06-08 2023-06-07 4 BIERMAN JAMES L NOVN Common Stock M - Exercise D 36.101 40.101
2023-06-08 2023-06-07 4 Skolsky Steven D NOVN Common Stock M - Exercise D 36.101 36.101
2023-06-08 2023-06-07 4 SANDERS MACHELLE NOVN Common Stock M - Exercise D 36.101 36.801
2022-04-11 2022-04-07 4 BIERMAN JAMES L NOVN Common Stock P - Purchase D 3,4488 1.000 3 4.000
2022-03-30 2022-03-28 4 BIERMAN JAMES L NOVN Common Stock P - Purchase D 3,4500 1.000 3 3.000
2022-03-28 2022-03-25 4 BIERMAN JAMES L NOVN Common Stock P - Purchase D 3,5450 2.000 7 2.000
2022-03-22 2022-03-18 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 3,6350 10.000 36 69.356
2022-03-22 2022-03-18 4 GAY JOHN M. NOVN Common Stock P - Purchase D 3,5000 1.000 4 2.500
2022-03-18 2022-03-17 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 3,3410 5.000 17 59.356
2022-03-18 2022-03-16 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 3,3370 5.000 17 54.356
2022-03-18 2022-03-11 4 John A. Donofrio NOVN Stock Option (Right to Buy) A - Award D 3,56 75.000 75.000
2022-01-25 2022-01-03 4 STAFFORD PAULA B NOVN Stock Option (Right to Buy) A - Award D 4,41 75.000 75.000
2021-11-12 2021-11-09 4 STAFFORD PAULA B NOVN Stock Option (Right to Buy) A - Award D 7,09 75.000 75.000
2021-05-28 2021-05-26 4 NOVAK ANDREW NOVN Stock Option (Right to Buy) A - Award D 9,19 7.550 7.550
2021-05-28 2021-05-26 4 BIERMAN JAMES L NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 SANDERS MACHELLE NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 KEEGAN ROBERT J NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 Geer W Kent NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 Skolsky Steven D NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 PALMOUR JOHN W NOVN Stock Option (Right to Buy) A - Award D 9,19 8.923 8.923
2021-05-28 2021-05-26 4 GAY JOHN M. NOVN Stock Option (Right to Buy) A - Award D 9,19 37.750 37.750
2021-05-19 2021-05-17 4 GAY JOHN M. NOVN Stock Option (Right to Buy) A - Award D 1,18 25.000 25.000
2021-05-19 2021-05-17 4 NOVAK ANDREW NOVN Stock Option (Right to Buy) A - Award D 1,18 15.000 15.000
2021-05-06 2021-05-04 4 Skolsky Steven D NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-05-06 2021-05-04 4 PALMOUR JOHN W NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-05-06 2021-05-04 4 BIERMAN JAMES L NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-05-06 2021-05-04 4 SANDERS MACHELLE NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-05-06 2021-05-04 4 KEEGAN ROBERT J NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-05-06 2021-05-04 4 Geer W Kent NOVN Stock Option (Right to Buy) A - Award D 1,29 35.000 35.000
2021-03-29 2021-03-26 4 STAFFORD PAULA B NOVN Common Stock P - Purchase D 1,4300 70.000 100 150.693
2021-03-02 2021-03-01 4 Skolsky Steven D NOVN Stock Option (Right to Buy) A - Award D 1,62 31.970 31.970
2020-09-25 2020-09-23 4 BIERMAN JAMES L NOVN Stock Option (Right to Buy) A - Award D 0,53 20.000 20.000
2020-08-19 2020-08-18 4 NOVAK ANDREW NOVN Stock Option (Right to Buy) A - Award D 0,53 20.000 20.000
2020-07-30 2020-07-28 4 Geer W Kent NOVN Stock Option (Right to Buy) A - Award D 0,78 20.000 20.000
2020-07-30 2020-07-28 4 KEEGAN ROBERT J NOVN Stock Option (Right to Buy) A - Award D 0,78 20.000 20.000
2020-07-30 2020-07-28 4 PALMOUR JOHN W NOVN Stock Option (Right to Buy) A - Award D 0,78 20.000 20.000
2020-07-30 2020-07-28 4 SANDERS MACHELLE NOVN Stock Option (Right to Buy) A - Award D 0,78 20.000 20.000
2020-07-30 2020-07-28 4 INGRAM ROBERT ALEXANDER NOVN Stock Option (Right to Buy) A - Award D 0,78 20.000 20.000
2020-04-08 2020-04-06 4 GAY JOHN M. NOVN Stock Option (Right to Buy) A - Award D 0,37 34.000 34.000
2020-03-05 2020-03-03 4 PALMOUR JOHN W NOVN Warrant (Right to Buy) P - Purchase D 0,30 200.000 200.000
2020-03-05 2020-03-03 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 200.000 493.568
2020-03-05 2020-03-03 4 SANDERS MACHELLE NOVN Warrant (Right to Buy) P - Purchase D 0,30 7.000 7.000
2020-03-05 2020-03-03 4 SANDERS MACHELLE NOVN Common Stock P - Purchase D 7.000 7.000
2020-02-04 2020-02-01 4 STAFFORD PAULA B NOVN Stock Appreciation Right A - Award D 0,82 600.000 600.000
2019-09-10 2019-09-06 4 STAFFORD PAULA B NOVN Stock Option (Right to Buy) A - Award D 2,68 130.000 130.000
2019-09-10 2019-09-06 4 GAY JOHN M. NOVN Stock Option (Right to Buy) A - Award D 2,68 5.000 5.000
2019-09-10 2019-09-06 4 NOVAK ANDREW NOVN Stock Option (Right to Buy) A - Award D 2,68 3.691 3.691
2019-08-02 2019-07-31 4 SANDERS MACHELLE NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-08-02 2019-07-31 4 Sun Eugene NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-08-02 2019-07-31 4 Martin G. Kelly NOVN Stock Appreciation Right A - Award D 3,80 1.000.000 1.000.000
2019-08-02 2019-07-31 4 PALMOUR JOHN W NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-08-02 2019-07-31 4 INGRAM ROBERT ALEXANDER NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-08-02 2019-07-31 4 KEEGAN ROBERT J NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-08-02 2019-07-31 4 Geer W Kent NOVN Stock Option (Right to Buy) A - Award D 2,63 20.000 20.000
2019-07-02 2019-07-02 4 Malin Life Sciences Holdings Ltd NOVN Common Stock S - Sale I 2,7500 -6.287 -17 2.598.485
2019-07-02 2019-07-01 4 Malin Life Sciences Holdings Ltd NOVN Common Stock S - Sale I 2,7400 -913 -3 2.604.772
2019-07-02 2019-06-28 4 Malin Life Sciences Holdings Ltd NOVN Common Stock S - Sale I 2,6900 -17.800 -48 2.605.685
2019-05-30 2019-05-29 4 Martin G. Kelly By George Kelly Martin IRRA FBO George Kelly Martin NOVN Common Stock P - Purchase I 1,9700 1.500 3 45.000
2019-05-29 2019-05-28 4 Martin G. Kelly By George Kelly Martin IRRA FBO George Kelly Martin NOVN Common Stock P - Purchase I 2,1500 3.500 8 43.500
2019-05-29 2019-05-24 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 2,2000 20.000 44 293.568
2019-05-23 2019-05-22 4 INGRAM ROBERT ALEXANDER NOVN Common Stock P - Purchase D 2,2100 50.000 110 169.777
2019-05-23 2019-05-21 4 Geer W Kent NOVN Common Stock P - Purchase D 1,9000 5.000 10 15.828
2019-05-21 2019-05-17 4 Martin G. Kelly By George Kelly Martin IRRA FBO George Kelly Martin NOVN Common Stock P - Purchase I 1,4300 40.000 57 40.000
2019-05-21 2019-05-17 4 Martin G. Kelly NOVN Common Stock P - Purchase D 1,4300 20.000 29 60.000
2019-05-21 2019-05-20 4 STAFFORD PAULA B NOVN Common Stock P - Purchase D 1,9200 80.000 154 80.693
2019-05-21 2019-05-17 4 STAFFORD PAULA B NOVN Common Stock P - Purchase D 1,4900 693 1 693
2019-05-21 2019-05-17 4 GAY JOHN M. NOVN Common Stock P - Purchase D 1,5000 14.900 22 15.000
2019-05-21 2019-05-17 4 NOVAK ANDREW By spouse NOVN Common Stock P - Purchase I 1,4700 5.400 8 6.700
2019-01-31 3 GAY JOHN M. NOVN Common Stock D 200
2019-01-31 3 GAY JOHN M. NOVN Common Stock D 200
2019-01-31 3 GAY JOHN M. NOVN Common Stock D 200
2019-01-30 2019-01-28 4 STAFFORD PAULA B NOVN Stock Option (Right to Buy) A - Award D 1,35 55.000 55.000
2018-10-01 2018-09-28 4 INGRAM ROBERT ALEXANDER NOVN Common Stock P - Purchase D 2,8400 50.000 142 119.777
2018-09-27 2018-09-26 4 Martin G. Kelly NOVN Common Stock P - Purchase D 2,7300 10.000 27 40.000
2018-08-24 2018-08-22 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 2,6600 20.000 53 273.568
2018-08-24 2018-08-22 4 HUNTER JEFF N NOVN Employee Stock Option (Right to Buy) M - Exercise D 1,12 -11.667 0
2018-08-24 2018-08-22 4 HUNTER JEFF N NOVN Common Stock M - Exercise D 1,1200 11.667 13 186.666
2018-08-23 2018-08-21 4 Martin G. Kelly NOVN Common Stock P - Purchase D 2,7100 30.000 81 30.000
2018-06-07 2018-06-04 4 Murphy Sean NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 KEEGAN ROBERT J NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 PALMOUR JOHN W NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 SANDERS MACHELLE NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 Geer W Kent NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 Sun Eugene NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-06-07 2018-06-04 4 INGRAM ROBERT ALEXANDER NOVN Stock Option (Right to Buy) A - Award D 3,08 20.000 20.000
2018-05-16 2018-05-12 4 NOVAK ANDREW NOVN Employee Stock Option (Right to Buy) A - Award D 3,14 3,1400 25.000 78 25.000
2018-04-23 3 NOVAK ANDREW By spouse NOVN Common stock I 2.600
2018-04-23 3 NOVAK ANDREW By spouse NOVN Common stock I 2.600
2018-04-23 3 NOVAK ANDREW By spouse NOVN Common stock I 2.600
2018-02-23 2018-02-12 4 HUNTER JEFF N NOVN Employee Stock Option (right to buy) A - Award D 3,03 35.000 35.000
2018-02-23 2018-02-12 4 STAFFORD PAULA B NOVN Employee Stock Option (right to buy) A - Award D 3,03 12.146 12.146
2018-02-23 2018-02-12 4 Stasko Nathan NOVN Employee Stock Option (right to buy) A - Award D 3,03 35.000 35.000
2018-02-21 2018-02-16 4 Sun Eugene NOVN Stock Option (right to buy) A - Award D 3,44 13.078 13.078
2018-01-26 3 GOODNIGHT JAMES H See Footnotes NOVN Common Stock I 4.858.298
2018-01-26 3 GOODNIGHT JAMES H See Footnotes NOVN Common Stock I 4.858.298
2018-01-26 3 GOODNIGHT JAMES H See Footnotes NOVN Common Stock I 4.858.298
2018-01-23 3 Parker Donald R See Footnotes NOVN Common Stock I 7.902.936
2018-01-23 3 Parker Donald R See Footnotes NOVN Common Stock I 7.902.936
2018-01-23 3 Parker Donald R NOVN Common Stock D 3.960.568
2018-01-23 3 Parker Donald R See Footnotes NOVN Common Stock I 3.958.768
2018-01-23 3 Parker Donald R NOVN Common Stock D 3.960.568
2018-01-23 3 Parker Donald R See Footnotes NOVN Common Stock I 3.958.768
2018-01-22 3 Reedy Creek Investments LLC NOVN Common Stock D 7.894.736
2018-01-22 3 Reedy Creek Investments LLC NOVN Common Stock D 7.894.736
2017-11-03 2017-11-01 4 HUNTER JEFF N NOVN Employee Stock Option (right to buy) A - Award D 5,48 25.000 50.000
2017-10-16 2017-10-12 4 STAFFORD PAULA B NOVN Employee Stock Option (right to buy) A - Award D 5,03 68.401 68.401
2017-09-26 2017-09-24 4 SANDERS MACHELLE NOVN Stock Option (right to buy) A - Award D 5,40 19.240 19.240
2017-09-18 2017-09-15 4 Hodges William L NOVN Employee Stock Option (right to buy) M - Exercise D 6,03 -5.000 28.000
2017-09-18 2017-09-15 4 Hodges William L NOVN Common Stock M - Exercise D 6,0300 5.000 30 5.000
2017-08-29 2017-08-29 4 INGRAM ROBERT ALEXANDER NOVN Common Stock P - Purchase D 4,7000 8.465 40 69.777
2017-08-29 2017-08-25 4 INGRAM ROBERT ALEXANDER NOVN Common Stock P - Purchase D 4,2500 3.535 15 61.312
2017-08-28 2017-08-25 4 STAFFORD PAULA B NOVN Employee Stock Option (right to buy) A - Award D 4,27 30.500 30.500
2017-08-25 2017-08-23 4 PALMOUR JOHN W NOVN Common Stock P - Purchase D 3,9900 12.000 48 253.568
2017-08-03 2017-08-01 4 HUNTER JEFF N NOVN Employee Stock Option (right to buy) A - Award D 5,48 25.000 25.000
2017-06-29 2017-06-28 4 Hodges William L NOVN Employee Stock Option (Right to Buy) A - Award D 4,08 8.000 8.000
2017-06-14 2017-06-12 4 Johnson Brian M. NOVN Employee Stock Option (right to buy) A - Award D 4,23 42.500 42.500
2017-06-14 2017-06-12 4 Stasko Nathan NOVN Employee Stock Option (right to buy) A - Award D 4,23 42.500 42.500
2017-06-07 2017-06-05 4 PALMOUR JOHN W NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-06-07 2017-06-05 4 Martin G. Kelly NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-06-07 2017-06-05 4 Murphy Sean NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-06-07 2017-06-05 4 INGRAM ROBERT ALEXANDER NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-06-07 2017-06-05 4 KEEGAN ROBERT J NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-06-07 2017-06-05 4 Geer W Kent NOVN Stock Option (right to buy) A - Award D 4,64 34.014 34.014
2017-03-28 2017-03-24 4 Hodges William L NOVN Employee Stock Option (right to buy) A - Award D 6,03 33.000 33.000
2017-03-24 2017-03-06 4 HUNTER JEFF N NOVN Employee Stock Option (right to buy) A - Award D 6,95 11.665 11.665
2016-11-04 2016-11-02 4 Rico M. Joyce NOVN Stock Option (right to buy) A - Award D 20,64 40.000 40.000
2016-11-04 2016-11-02 4 Johnson Brian M. NOVN Stock Option (Right to Buy) A - Award D 20,64 10.000 10.000
2016-09-28 2016-09-26 4 PALMOUR JOHN W NOVN Mezzanine B Stock C - Conversion D -9.455 0
2016-09-28 2016-09-26 4 PALMOUR JOHN W NOVN Mezzanine A Stock C - Conversion D -44.976 0
2016-09-28 2016-09-26 4 PALMOUR JOHN W NOVN Series 4 Preferred Stock C - Conversion D -152.778 0
2016-09-28 2016-09-26 4 PALMOUR JOHN W By Palmour 2012 Irrevocable Children's Trust NOVN Series 3 Preferred Stock C - Conversion I -274.875 0
2016-09-28 2016-09-26 4 PALMOUR JOHN W NOVN Series 3 Preferred Stock C - Conversion D -34.359 0
2016-09-28 2016-09-26 4 PALMOUR JOHN W By Palmour 2012 Irrevocable Children's Trust NOVN Common Stock C - Conversion I 274.875 274.875
2016-09-28 2016-09-26 4 PALMOUR JOHN W NOVN Common Stock C - Conversion D 241.568 241.568
2016-09-28 2016-09-26 4 KEEGAN ROBERT J NOVN Mezzanine B Stock C - Conversion D -63.035 0
2016-09-28 2016-09-26 4 KEEGAN ROBERT J NOVN Common Stock C - Conversion D 63.035 63.035
2016-09-28 2016-09-26 4 HUNTER JEFF N By spouse NOVN Series 1 Preferred Stock C - Conversion I -41.666 0
2016-09-28 2016-09-26 4 HUNTER JEFF N NOVN Series 1 Preferred Stock C - Conversion D -141.666 0
2016-09-28 2016-09-26 4 HUNTER JEFF N By spouse NOVN Common Stock C - Conversion I 41.666 41.666
2016-09-28 2016-09-26 4 HUNTER JEFF N NOVN Common Stock C - Conversion D 141.666 174.999
2016-09-28 2016-09-26 4 INGRAM ROBERT ALEXANDER NOVN Series 4 Preferred Stock C - Conversion D -27.777 0
2016-09-28 2016-09-26 4 INGRAM ROBERT ALEXANDER NOVN Common Stock C - Conversion D 27.777 57.777
2016-09-28 2016-09-26 4 Geer W Kent NOVN Mezzanine A Stock C - Conversion D -6.078 0
2016-09-28 2016-09-26 4 Geer W Kent NOVN Common Stock C - Conversion D 6.078 10.828
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Mezzanine A Stock C - Conversion D -98.467 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Series 4 Preferred Stock C - Conversion D -87.033 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Series 3 Preferred Stock C - Conversion D -148.885 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Series 2 Preferred Stock C - Conversion D -379.307 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Series 1 Preferred Stock C - Conversion I -478.280 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Series 1 Preferred Stock C - Conversion D -329.938 0
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Common Stock C - Conversion I 478.280 478.280
2016-09-28 2016-09-26 4 HUNTER F NEAL NOVN Common Stock C - Conversion D 1.043.630 1.043.630
2016-09-28 2016-09-26 4 Malin Life Sciences Holdings Ltd NOVN Mezzanine A Stock C - Conversion I -1.823.485 0
2016-09-28 2016-09-26 4 Malin Life Sciences Holdings Ltd NOVN Common Stock P - Purchase I 11,0000 800.000 8.800 2.623.485
2016-09-28 2016-09-26 4 Malin Life Sciences Holdings Ltd NOVN Common Stock C - Conversion I 1.823.485 1.823.485
2016-09-22 2016-09-20 4 KEEGAN ROBERT J NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-22 2016-09-20 4 PALMOUR JOHN W NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-22 2016-09-20 4 INGRAM ROBERT ALEXANDER NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-22 2016-09-20 4 Geer W Kent NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-22 2016-09-20 4 Martin G. Kelly NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-22 2016-09-20 4 Murphy Sean NOVN Stock Option A - Award D 11,00 14.484 14.484
2016-09-20 3 HUNTER JEFF N NONE Common Stock D 66.666
2016-09-20 3 HUNTER JEFF N NONE Common Stock D 66.666
2016-09-20 3 Stasko Nathan NONE Common Stock D 1.647.666
2016-09-20 3 Stasko Nathan NONE Common Stock D 1.647.666
2016-09-20 3 Rico M. Joyce By M. Joyce Rico Revocable Trust NONE Common Stock I 131.666
2016-09-20 3 Rico M. Joyce By M. Joyce Rico Revocable Trust NONE Common Stock I 131.666
2016-09-20 3 INGRAM ROBERT ALEXANDER NONE Common Stock D 60.000
2016-09-20 3 INGRAM ROBERT ALEXANDER NONE Common Stock D 60.000
2016-09-20 3 Johnson Brian M. By Johnson Family Revocable Trust NONE Common Stock I 25.000
2016-09-20 3 Johnson Brian M. By Johnson Family Revocable Trust NONE Common Stock I 25.000
2016-09-20 3 Geer W Kent NONE Common Stock D 9.500
2016-09-20 3 Geer W Kent NONE Common Stock D 9.500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista